Equip Your Facility for the Bariatric Resident Obesity has been rapidly increasing in the United States over the past two decades. Beyond being a major health concern, obesity can also have implications for how your facility provides care. According to the most current data from the CDC, 35.4 percent of adults over the age of 60 are obese.1 (To be considered obese, an adult needs to have a body mass index, or BMI, of 30 or higher.) The increasing number of obese seniors is leading to facilities bringing in new, specially designed equipment because standard-sized products might not be able to accommodate residents with bariatric proportions. Fortunately, manufacturers are in tune with the rise in obesity and have developed products with this population in mind. ProMed's comprehensive Bariatric Equipment & Accessories product category was designed to help you meet the special needs of this group. We offer:
Reference 1 Centers for Disease Control and Prevention. Adult Obesity Facts. Available at: http://www.cdc.gov/obesity/data/adult.html. Accessed May 29, 2014. |
FDA Approves Drug to Treat MRSA, Other Skin Infections The FDA has approved an antibacterial drug designed to treat adults with skin infections including Staphyloccous aureus (including MRSA) and Streptococcus pyogenes. The intravenous drug, Dalvance, is the first drug designated as a Qualified Infectious Disease Product to receive FDA approval. It received this label under the Generating Antibiotic Incentives Now (GAIN) portion of the FDA Safety and Innovation Act, the agency's program for encouraging increased development and approval of new antibacterial drugs. Dalvance is marketed by Chicago-based Durata Therapeutics. To learn more, click here. |
Product pricing is only visible to registered promedsupply.com customers. If you are not yet registered, give us a call at (800) 648-5190 and our Customer Care Professionals will be happy to get you set up. |